Catalyst Pharmaceuticals, Inc. (CPRX)
24.69
-0.13
(-0.52%)
USD |
NASDAQ |
Apr 02, 16:00
24.76
+0.07
(+0.28%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap : 2.997B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 2.210B |
| ANI Pharmaceuticals, Inc. | 1.626B |
| Inovio Pharmaceuticals, Inc. | 50.48M |
| Indivior Pharmaceuticals, Inc. | 3.696B |
| United Therapeutics Corp. | 24.50B |
Market Cap Related Metrics
| PE Ratio | 14.66 |
| PS Ratio | 5.334 |
| PEG Ratio | 0.5106 |
| Price to Book Value | 3.160 |
| Price to Free Cash Flow | 15.06 |
| Price | 24.69 |
| Earnings Yield | 6.82% |
| PEGY Ratio | 0.5106 |
| Operating PE Ratio | 12.19 |
| Normalized PE Ratio | 14.71 |